m2 day 3 Flashcards

1
Q

substance use disorders

3 key points, characterized by, criteria 11

A

key points:
- Chronic
- Recurrent
- Compulsive

Characterized by
- continued use despite physical and psychological harms
- Occurs over time and alters the brain’s structure –> lose control over their use of substances

Disorder based on 11 diagnostic criteria and must present within a 12 month period:
2-3 criteria is required for mild substance use
4-5 is moderate,
6-7 is severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

11 diagnostic criteria of substance use

A
  1. large amounts or over a longer period of time than intended.

  2. desire or unsuccessful efforts to cut down or control substance use.

  3. A great deal of time is spent in activities necessary to obtain, use, or recover from effects of the substance.

  4. Craving, or a strong desire to use.

  5. failure to fulfill major role obligations at work, school or home.
  6. Continued use despite having persistent social or interpersonal problems caused or exacerbated by the effects of substance

    • Important social, occupational or recreational activities are given up or reduced because of use.

  7. Recurrent use in situations in which it is physically hazardous

  8. Continued use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance.

  9. Tolerance
  10. Withdrawal,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

4 C’s of substance use

A

Compulsive Use
Cravings
Continued Use
- Despite Serious Consequences

Can’t Stop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

bioogical and psychological factors to substance use

SPRTI, personality, psychoanalytical, developmental

A

cBiology – brain changes with prolonged substance use
- Increased reinforcement mechanism of the brain (dopamine)
- Physiological brain changes alter one’s judgement, decision making, learning, memory and behavioural control.
- Use not only for pleasure, but for survival.

Psychological factors
- Substances = Pleasure = Repeated use = Tolerance = Increased use
- Personality traits: neuroticism, impulsivity, and extroversion.
- Psychoanalytical: Conflicts with the ‘self’ (Unresolved issues of the Ego)
- Developmental Theory: Substances fill empty space left by lack of attachment during childhood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

probelms associated w substance use disorder

A
  • Infectious diseases (hepatitis B & C, HIV, STIs, TB)
  • Injection-related infections (cellulitis, abscess, thrombophlebitis, endocarditis, sepsis)
  • Overdose (fatal and non-fatal)
  • Concurrent disorders: anxiety related disorders, mood disorders, eating disorders
  • Social problems (dysfunctional family life, difficulties with employment, incarceration)
  • pain, suicide/self-harm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

substances

SNC depressors

A

Sedatives, hypnotics, anxiolytics
Synthetic medications that are sedating, induce sleep and reduce anxiety
- Benzodiazepines: diazepam, oxazepam, temazepam, lorazepam
- Flunitrazepam (ruffies, rophies, roachies) which is the ‘date rape’ drug
- GHB is another illegal drug frequently used in the club scene
- Use of these drugs typically co-occurs with alcohol making their use extremely dangerous
- Side effects related to benzodiazepine withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

substances

Alcohol

A
  • Alcohol reaches all tissues in the body and crosses the placenta resulting in teratogenic effects to the developing fetus
  • Can worsen existing psychiatric conditions (increase the risk of depression, suicide, homicide and the risk of harm to self and others)
  • Excessive or long-term use of alcohol can adversely affect all body systems (itis and opathies).
  • Can lead to varying degrees of cognitive impairment (Wernick-Korsakoff’s syndrome – thiamine deficiency)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

alcohol withdrawl and pharmacotherapy

minor, intermediate, major W

A

Minor withdrawal -
- may include anxiety, nausea and vomiting, coarse tremor, sweating, tachycardia, hypertension, head ache, insomnia – usually resolved within 48-72 hours.

Intermediate withdrawal
- patients experience minor withdrawal symptoms in addition to seizures, dysrhythmias, and/or hallucinations, - patients remain aware of the unreal nature of their auditory or visual hallucinations and remain oriented and alert.

Major withdrawal (delirium tremens)
- severe agitation, gross tremulousness, marked psychomotor and autonomic hyperactivity, global confusion, disorientation and auditory, visual or tactile hallucinations.
- Tends to occur 5 or 6 days after severe untreated withdrawal and sudden death may occur.

pharm
- benzos –> dangerous withdrawl symtpmos
- thiamine –> reduce ataxia
- folic acid –> deificiency so we want to supplement
- supplementation of lost electrolytes -
- disulfram
- nalextrone –> opiod antagonist
- acamprosate –> cravings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

opioids and pharmacotherapy

types of opiods, withdrawl and pharm

A

Opioids can be licit or illicit drugs
- Naturally occurring : Morphine and codeine
- Semi-synthetic: Heroin
- Synthetic: oxycodone, methadone, fentanyl, merperidine, hydrocodone, propoxyphene, tramadol, etc.
- Act by attaching to the endogenous opioid receptors in the brain

withdrawl
- When opioids are discontinued, symptoms may include severe cravings, severe respiratory and gastrointestinal side effects – typically not life threatening but very uncomfortable

phram
- naloxone (narcan) and methadone
- symtpm tx aswell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

opiod overdose risk factors and signs

A

Opioid overdose risk factors
- Decreased tolerance
- Mixing drugs
- Using alone
- Drug quality and potency
Health status
Route

Opioid Overdose – Signs
- Decreased level of consciousness
- Decreased respiratory rate (<12/min)
- Meiotic (constricted) pupils
- Hypoxia
- Naloxone = Antidote

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

stimulant

cocaine

A
  • Snorted, smoked, or injected
  • Crack cocaine (crystalized): Faster Acting
  • Rapidly crosses the blood-brain barrier
  • Physical effects: alertness and energy and bizarre behaviours potentially leading to violence and potential risk of harm, tachycardia or bradycardia, pupil dilation, hypo or hyper tension, nasal septum destruction, respiratory distress, chest pain, arrhythmias, seizures, coma
  • The high is followed by a significant and intense depressive phase (“the crash”) resulting in irritability fatigue, mood depression, lethargy, abdominal and muscle cramps, dehydration, apathy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

stimulant

amphetamines

A
  • Methamphetamines, amphetamines, methylphenidate, dextroamphetamine and some diet medications.
  • Can be taken orally, snorted, smoked or injected.
  • Act like adrenaline and activate the CNS and peripheral nervous system.
  • Increases alertness, concentration, energy, euphoria… suppreses appetite.
  • Similar presentation as cocaine except for its analgesic effect.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

5 A’s of smoking cessation and pharmacotherapy

A

The 5A’s of smoking cessation

1. Ask patients about their smoking status
2. Advise them to quit
3. Assess their readiness to quit
4. Assist them in their attempts to quit or promote motivation for them to quit
5. Arrange for follow-up

pharm
- Nicotine replacement therapy (NRT)
- Bproprion (Wellbutrin, Zyban)
- Varenicline (Champix)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hallucinogens

psyc /pysical effects

A

Psychological effects:
- Paranoia, anxiety, depression, synesthesia, hallucinations, judgement alterations.

Physical effects:
- Pupil dilation, tachycardia, diaphoresis, tremors, palpitations, lack of coordination, increased temperature, pulse and respirations, muscle rigidity, seizures, agitation.

3 groups (see Table 18-11):
1. Indolealkylamines (ex: LSD, psilocybin):
- No secondary stimulant effect.
1. Phenylethylamines (ex: mescaline, ecstasy, MDMA): Secondary stimulant effect.
1. Arylcyclohexylamines (Dissociative aneasthetics - ex: PCP, Ketamine):
- Secondary depressant effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cannabis

A
  • Body stores cannabinoids in fat tissue and in the brain causing urine drug screens to remain positive for weeks.
  • May result in the development of psychotic symptoms and the use of cannabis –> recognized as an independent risk factor for the development of schizophrenia and psychosis.
  • Synthetically produced to treatment selected medical conditions/symptoms (e.g., appetite stimulations, pain, MS, nausea)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

inhalents

A
  • Refers to a group of chemical vapors or gases that when inhaled cause a high.
  • They are not intended for human consumption and typically cause CNS depression.
  • Includes substances such as acetone, felt-tip markers, hobby glue, rubber cement, dry cleaning fluid, paint and nail polish removers, paint thinners, aerosols, chloroform, butane, propane, nitrites.
  • damage to the liver, kidney, lungs, and heart, bone marrow suppression, and cause permanent brain damage.
  • death is not dose dependant
17
Q

types of care for substance use

A

Outpatient treatment:
- usually includes both group and individual sessions totaling fewer than 9 hours/week.

Intensive outpatient treatment (including partial hospitalization):
- Structured programs that include both individual and group sessions totaling greater than 9 hours/week.

Healing Lodge:
- Indigenous treatment approach
- 6-week residential treatment program where the person’s emotional and psychic issues (self-esteem, anger, grief, trauma, etc.) are addressed alongside the substance use disorder.

Medically monitored intensive inpatient treatment (residential):
- organized addiction services, around-the-clock professionally directed evaluation and care.

Medically managed intensive inpatient treatment:
- Most intensive level of care that takes places 24 hours/day in an acute care inpatient unit to medically manage those suffering from severe withdrawal

18
Q

Motivational interviewing and stages of change model

A

MI is a directive, patient-centered style of counseling that helps patients to explore and resolve their ambivalence about changing their behaviors.

MI is based on the stages of change model:
1. Pre-contemplation – person has no intention to quit in the next 6 months
2. Contemplation – person is aware that the 
problem exists and is seriously 
considering making change but has 
not planned to do so.
3. Preparation – person has made a decision 
to quit within the next 30 days.
4. Action – person has quit within the past 6 months and is actively applying cessation skills.
5. Maintenance – person has quit for more than 6 months.

19
Q

psycosocial interventions for alcohol use

A
  • Cognitive-Behavioural Therapy (CBT)
  • Contingency Management (Behavior Therapy) – e.g., Token economy
  • Twelve-Step Facilitation (TSF)

Alcoholics Anonymous (AA)
- Only criterion to join is the “desire to quit drinking”
- Ongoing meetings with hope instilled through others who are no longer drinking
- Focus is on abstinence and the loss of control over the ability to drink
- Success is attained by taking it “one day at a time”